Literature DB >> 17423103

Clostridium perfringens Type C Enterotoxemia.

L Niilo.   

Abstract

Forms of enteric disease caused by Clostridium perfringens type C are critically reviewed with emphasis on practical aspects and recent research findings. Available data indicate that more animal species may be fatally infected by type C of this organism than by any other type of C. perfringens. Fatal cases have been recorded in pigs, cattle, sheep, horses and humans. Newborn animals are typically the most susceptible, possibly related to aspects of bacterial colonization, intestinal digestive functions, and to some other, unexplained, factors. Both beta toxin and the bacterial cells are required to initiate pathogenesis at the tips of jejunal villi, and subsequent massive adherence of these cells to necrotic mucosa is a characteristic feature. Although major lesions occur in the intestine, death is due to toxemia. The disease can be effectively controlled by vaccination of the dam. Epizootiology of this disease is a possible area for further studies.

Entities:  

Year:  1988        PMID: 17423103      PMCID: PMC1680772     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  46 in total

Review 1.  Current progress in reducing salmonella colonization of poultry by 'competitive exclusion'.

Authors:  G C Mead; C S Impey
Journal:  Soc Appl Bacteriol Symp Ser       Date:  1986

2.  Pharmacological effect of beta toxin of Clostridium perfringens type C on rats.

Authors:  J Sakurai; Y Fujii; M Matsuura; K Endo
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

3.  [Clostridium perfringens type C enterotoxemia (necrotizing enteritis) in suckling pigs. 2. Light and electron microscopic studies of the pathology and pathogenesis of experimental Clostridium perfringens type C toxin poisoning].

Authors:  U Johannsen; S Menger; W Erwerth; B Köhler
Journal:  Arch Exp Veterinarmed       Date:  1986-11

4.  Clostridium perfringens type C enterotoxemia in a newborn foal.

Authors:  M Howard-Martin; R J Morton; C W Qualls; C G MacAllister
Journal:  J Am Vet Med Assoc       Date:  1986-09-01       Impact factor: 1.936

5.  Scanning electronmicroscopy of the jejunum in enteritis necroticans.

Authors:  P D Walker; T G Murrell; L K Nagy
Journal:  J Med Microbiol       Date:  1980-08       Impact factor: 2.472

6.  Experimental pigbel: the production and pathology of necrotizing enteritis due to Clostridium welchii type C in the guinea-pig.

Authors:  G Lawrence; R Cooke
Journal:  Br J Exp Pathol       Date:  1980-06

Review 7.  Clostridium perfringens in animal disease: a review of current knowledge.

Authors:  L Niilo
Journal:  Can Vet J       Date:  1980-05       Impact factor: 1.008

8.  Antagonistic effect exerted by three strictly anaerobic strains against various strains of Clostridium perfringens in gnotobiotic rodent intestines.

Authors:  N Yurdusev; J L Nicolas; M Ladire; R Ducluzeau; P Raibaud
Journal:  Can J Microbiol       Date:  1987-03       Impact factor: 2.419

9.  An affinity technique for the isolation of Clostridium perfringens type C from man and pigs in Papua New Guinea.

Authors:  G Lawrence; R Brown; J Bates; A Saul; M Davis; R Spark; G Anian
Journal:  J Appl Bacteriol       Date:  1984-10

10.  Experimental production of hemorrhagic enterotoxemia by Clostridium perfringens type C in maturing lambs.

Authors:  L Niilo
Journal:  Can J Vet Res       Date:  1986-01       Impact factor: 1.310

View more
  19 in total

Review 1.  Recent progress in understanding the pathogenesis of Clostridium perfringens type C infections.

Authors:  F A Uzal; B A McClane
Journal:  Vet Microbiol       Date:  2011-02-26       Impact factor: 3.293

2.  Necrohemorrhagic enterocolitis caused by Clostridium perfringens type C in a foal.

Authors:  R Drolet; R Higgins; A Cécyre
Journal:  Can Vet J       Date:  1990-06       Impact factor: 1.008

Review 3.  Clostridial enteric diseases of domestic animals.

Authors:  J G Songer
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

4.  Adult necrotising enterocolitis-pig-bel disease: a Pacific disease in London.

Authors:  Justin Conrad Rosen Wormald; Sanjay Dindyal; Francesca Mellor; Nebil Behar
Journal:  BMJ Case Rep       Date:  2016-10-28

5.  Molecular typing and epidemiological survey of prevalence of Clostridium perfringens types by multiplex PCR.

Authors:  H S Yoo; S U Lee; K Y Park; Y H Park
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 6.  Animal models to study the pathogenesis of human and animal Clostridium perfringens infections.

Authors:  Francisco A Uzal; Bruce A McClane; Jackie K Cheung; James Theoret; Jorge P Garcia; Robert J Moore; Julian I Rood
Journal:  Vet Microbiol       Date:  2015-02-25       Impact factor: 3.293

7.  Effects of Clostridium perfringens beta-toxin on the rabbit small intestine and colon.

Authors:  Jorge E Vidal; Bruce A McClane; Juliann Saputo; Jaquelyn Parker; Francisco A Uzal
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

8.  Contact with enterocyte-like Caco-2 cells induces rapid upregulation of toxin production by Clostridium perfringens type C isolates.

Authors:  Jorge E Vidal; Kaori Ohtani; Tohru Shimizu; Bruce A McClane
Journal:  Cell Microbiol       Date:  2009-04-30       Impact factor: 3.715

9.  Expression, crystallization and preliminary X-ray diffraction studies of recombinant Clostridium perfringens beta 2-toxin.

Authors:  Abhijit A Gurjar; Neela H Yennawar; Hemant P Yennawar; Kanagalaghatta R Rajashankar; Narasimha V Hegde; Bhushan M Jayarao
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-05-05

10.  Development and application of new mouse models to study the pathogenesis of Clostridium perfringens type C Enterotoxemias.

Authors:  Francisco A Uzal; Juliann Saputo; Sameera Sayeed; Jorge E Vidal; Derek J Fisher; Rachael Poon; Vicki Adams; Mariano E Fernandez-Miyakawa; Julian I Rood; Bruce A McClane
Journal:  Infect Immun       Date:  2009-10-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.